BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 188441)

  • 1. Relationship of oral contraception to development of trophoblastic tumour after evacuation of a hydatidiform mole.
    Stone M; Dent J; Kardana A; Bagshawe KD
    Br J Obstet Gynaecol; 1976 Dec; 83(12):913-6. PubMed ID: 188441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptives and postmolar trophoblastic disease.
    Berkowitz RS; Goldstein DP; Marean AR; Bernstein M
    Obstet Gynecol; 1981 Oct; 58(4):474-7. PubMed ID: 6269038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy.
    Stone M; Bagshawe KD
    Br J Obstet Gynaecol; 1979 Oct; 86(10):782-92. PubMed ID: 228696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
    Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
    Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group Study).
    Curry SL; Schlaerth JB; Kohorn EI; Boyce JB; Gore H; Twiggs LB; Blessing JA
    Am J Obstet Gynecol; 1989 Apr; 160(4):805-9; discussion 809-11. PubMed ID: 2540654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormonal contraception after evacuation of hydatid mole (author's transl)].
    Donát J; Chalupa M
    Cesk Gynekol; 1981 May; 46(4):286-9. PubMed ID: 7249096
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of patients with persistent trophoblastic disease after complete hydatidiform mole by using a normal 24-hour urine hCG regression curve.
    van Cromvoirt SM; Thomas CM; Quinn MA; McNally OM; Bekkers RL
    Gynecol Oncol; 2014 Jun; 133(3):542-5. PubMed ID: 24631700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.
    Braga A; Maestá I; Short D; Savage P; Harvey R; Seckl MJ
    BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The excretion of chorionic gonadetropin in 55 cases of hydatidiform mole (author's transl)].
    Lichtenegger W; Weiss PA
    Geburtshilfe Frauenheilkd; 1977 Apr; 37(4):334-7. PubMed ID: 192629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
    Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
    Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexisting epithelioid trophoblastic tumor and choriocarcinoma of the uterus following a chemoresistant hydatidiform mole.
    Shen DH; Khoo US; Ngan HY; Ng TY; Chau MT; Xue WC; Cheung AN
    Arch Pathol Lab Med; 2003 Jul; 127(7):e291-3. PubMed ID: 12823059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trophoblastic tumour, oral contraceptive therapy and pregnancy associated alpha2-glycoprotein (PAAG), case report.
    Teisner B; Mogensen B; Folkersen J; Svehag SE
    Br J Obstet Gynaecol; 1977 Aug; 84(8):630-2. PubMed ID: 196614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of hysteroscopy in diagnosis and management of trophoblastic disease].
    Suzuki A; Kawaguchi K; Konishi I; Ida K; Fujii S; Matsuura S
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Feb; 36(2):255-60. PubMed ID: 6321615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subsequent pregnancy outcome in patients with spontaneous resolution of HCG after evacuation of hydatidiform mole: comparison between complete and partial mole.
    Matsui H; Iitsuka Y; Suzuka K; Seki K; Sekiya S
    Hum Reprod; 2001 Jun; 16(6):1274-7. PubMed ID: 11387305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydatidiform mole and persistent trophoblastic disease in adolescents.
    Parrish SK
    J Pediatr; 1986 Nov; 109(5):838-40. PubMed ID: 2430085
    [No Abstract]   [Full Text] [Related]  

  • 16. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of hydatidiform mole after primary evacuation.
    Lurain JR; Brewer JI; Torok EE; Halpern B
    Am J Obstet Gynecol; 1983 Mar; 145(5):591-5. PubMed ID: 6829636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
    Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC
    Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of oral contraceptives and the intrauterine contraceptive devices to the regression of concentrations of the beta subunit of human chorionic gonadotropin and invasive complications after molar pregnancy.
    Ho Yuen B; Burch P
    Am J Obstet Gynecol; 1983 Jan; 145(2):214-7. PubMed ID: 6849356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve.
    Morrow P; Nakamura R; Schlaerth J; Gaddis O; Eddy G
    Am J Obstet Gynecol; 1985 Apr; 151(7):906-14. PubMed ID: 2580438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.